{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:17:44Z","timestamp":1790788664464,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":740,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","award":["MIS F.4520.20"],"award-info":[{"award-number":["MIS F.4520.20"]}],"id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1038\/s41379-020-0637-6","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T02:29:27Z","timestamp":1596076167000},"page":"116-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Treatment algorithm and prognostic factors for patients with stage I\u2013III carcinoma of the anal canal: a 20-year multicenter study"],"prefix":"10.1016","volume":"34","author":[{"given":"Diane","family":"Bruyere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Monnien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prudence","family":"Colpart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Roncarati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucine","family":"Vuitton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Hendrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Lepinoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Luquain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Pilard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lerho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9","family":"Molimard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Maingon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Arnould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Bone-Lepinoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Dusserre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Reynders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Ancion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Peiffert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Leroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Hubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Delhorme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Ghnassia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Woronoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Delvenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Pr\u00e9tet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Bosset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Peulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Mougin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Valmary-Degano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Herfs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-020-0637-6_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1038\/s41379-020-0637-6_bib2","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1200\/JCO.2012.45.2524","article-title":"Changing patterns of anal canal carcinoma in the United States","volume":"31","author":"Nelson","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-020-0637-6_bib3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2559.1994.tb01370.x","article-title":"Anal carcinoma\u2013a histological review","volume":"25","author":"Williams","year":"1994","journal-title":"Histopathology"},{"key":"10.1038\/s41379-020-0637-6_bib4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1473-3099(17)30653-9","article-title":"Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis","volume":"18","author":"Lin","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1038\/s41379-020-0637-6_bib5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1200\/JCO.2017.74.9291","article-title":"Anal cancer risk among people with HIV infection in the United States","volume":"36","author":"Colon-Lopez","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-020-0637-6_bib6","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"Bartelink","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-020-0637-6_bib7","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","article-title":"Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study","volume":"14","author":"Flam","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-020-0637-6_bib8","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/bjc.2014.467","article-title":"Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option","volume":"111","author":"Meulendijks","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1038\/s41379-020-0637-6_bib9","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","article-title":"Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial","volume":"299","author":"Ajani","year":"2008","journal-title":"JAMA"},{"key":"10.1038\/s41379-020-0637-6_bib10","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 \u00d7 2 factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1038\/s41379-020-0637-6_bib11","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1016\/j.ejca.2009.06.020","article-title":"Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014)","volume":"45","author":"Matzinger","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1038\/s41379-020-0637-6_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.21037\/tgh.2019.08.02","article-title":"Anal cancer and immunotherapy-are we there yet?","volume":"4","author":"Bian","year":"2019","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1038\/s41379-020-0637-6_bib13","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1200\/JCO.2013.52.3464","article-title":"Human papillomavirus genotyping and p16 expression as prognostic factors for patients with American Joint Committee on Cancer stages I to III carcinoma of the anal canal","volume":"32","author":"Serup-Hansen","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-020-0637-6_bib14","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/bjc.2015.20","article-title":"HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53","volume":"112","author":"Meulendijks","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1038\/s41379-020-0637-6_bib15","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/path.4858","article-title":"Proteomic signatures reveal a dualistic and clinically relevant classification of anal canal carcinoma","volume":"241","author":"Herfs","year":"2017","journal-title":"J Pathol"},{"key":"10.1038\/s41379-020-0637-6_bib16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/cmi.2010.56","article-title":"A reversed CD4\/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4(+)FOXP3(+) regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix","volume":"8","author":"Shah","year":"2011","journal-title":"Cell Mol Immunol"},{"key":"10.1038\/s41379-020-0637-6_bib17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1158\/0008-5472.CAN-12-2606","article-title":"PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer","volume":"73","author":"Badoual","year":"2013","journal-title":"Cancer Res"},{"key":"10.1038\/s41379-020-0637-6_bib18","doi-asserted-by":"crossref","first-page":"E26","DOI":"10.1002\/ijc.27776","article-title":"CD8-alpha T-cell infiltration in human papillomavirus-related oropharyngeal carcinoma correlates with improved patient prognosis","volume":"132","author":"Jung","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1038\/s41379-020-0637-6_bib19","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/bjc.2015.277","article-title":"Stromal infiltration of CD8 T cells is associated with improved clinical outcome in HPV-positive oropharyngeal squamous carcinoma","volume":"113","author":"Oguejiofor","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1038\/s41379-020-0637-6_bib20","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/s41416-018-0049-2","article-title":"A dualistic model of primary anal canal adenocarcinoma with distinct cellular origins, etiologies, inflammatory microenvironments and mutational signatures: implications for personalised medicine","volume":"118","author":"Herfs","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1038\/s41379-020-0637-6_bib21","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/sj.bjc.6603300","article-title":"Factors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studies","volume":"95","author":"de Graeff","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1038\/s41379-020-0637-6_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"key":"10.1038\/s41379-020-0637-6_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jviromet.2011.04.006","article-title":"Comparison of the Abbott RealTime High Risk HPV test and INNO-LiPA HPV Genotyping Extra test for the detection of human papillomaviruses in formalin-fixed, paraffin-embedded cervical cancer specimens","volume":"175","author":"Kocjan","year":"2011","journal-title":"J Virol Methods"},{"key":"10.1038\/s41379-020-0637-6_bib24","doi-asserted-by":"crossref","first-page":"64910","DOI":"10.18632\/oncotarget.11912","article-title":"Immunohistochemical correlates of TP53 somatic mutations in cancer","volume":"7","author":"Murnyak","year":"2016","journal-title":"Oncotarget"},{"key":"10.1038\/s41379-020-0637-6_bib25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1056\/NEJMra1715715","article-title":"Head and neck cancer","volume":"382","author":"Chow","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-020-0637-6_bib26","first-page":"141","article-title":"Human papillomavirus in oropharyngeal cancer: the changing face of a disease","volume":"1866","author":"Mallen-St Clair","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1038\/s41379-020-0637-6_bib27","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.3748\/wjg.v21.i8.2294","article-title":"Anal cancer treatment: current status and future perspectives","volume":"21","author":"Ghosn","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1038\/s41379-020-0637-6_bib28","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.ijrobp.2015.08.004","article-title":"Prognostic relevance of HPV Infection and p16 overexpression in squamous cell anal cancer","volume":"93","author":"Mai","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1038\/s41379-020-0637-6_bib29","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ijc.28979","article-title":"Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy","volume":"136","author":"Rodel","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1038\/s41379-020-0637-6_bib30","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.radonc.2014.11.013","article-title":"Influence of human papillomavirus and p16(INK4a) on treatment outcome of patients with anal cancer","volume":"113","author":"Koerber","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1038\/s41379-020-0637-6_bib31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12876-018-0758-2","article-title":"HPV positive, wild type TP53, and p16 overexpression correlate with the absence of residual tumors after chemoradiotherapy in anal squamous cell carcinoma","volume":"18","author":"Soares","year":"2018","journal-title":"BMC Gastroenterol"},{"key":"10.1038\/s41379-020-0637-6_bib32","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1158\/1078-0432.CCR-07-1402","article-title":"Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck","volume":"14","author":"Westra","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-020-0637-6_bib33","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/cas.12369","article-title":"Human papillomavirus and p53 mutations in head and neck squamous cell carcinoma among Japanese population","volume":"105","author":"Maruyama","year":"2014","journal-title":"Cancer Sci"},{"key":"10.1038\/s41379-020-0637-6_bib34","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/bjc.1994.138","article-title":"p53 mutations in cervical carcinogenesis\u2013low frequency and lack of correlation with human papillomavirus status","volume":"69","author":"Busby-Earle","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1038\/s41379-020-0637-6_bib35","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type","volume":"141","author":"de Martel","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1038\/s41379-020-0637-6_bib36","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.ijrobp.2017.03.024","article-title":"Clinical advances of hypoxia-activated prodrugs in combination with radiation therapy","volume":"98","author":"Mistry","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1038\/s41379-020-0637-6_bib37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(18)32752-1","article-title":"Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial","volume":"393","author":"Mehanna","year":"2019","journal-title":"Lancet"},{"key":"10.1038\/s41379-020-0637-6_bib38","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1056\/NEJM199904153401502","article-title":"Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer","volume":"340","author":"Rose","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-020-0637-6_bib39","doi-asserted-by":"crossref","first-page":"e577","DOI":"10.1016\/j.ijrobp.2011.05.002","article-title":"Randomized clinical trial of weekly vs. triweekly cisplatin-based chemotherapy concurrent with radiotherapy in the treatment of locally advanced cervical cancer","volume":"81","author":"Ryu","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1038\/s41379-020-0637-6_bib40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.virusres.2016.11.006","article-title":"Modulation of the DNA damage response during the life cycle of human papillomaviruses","volume":"231","author":"Anacker","year":"2017","journal-title":"Virus Res"},{"key":"10.1038\/s41379-020-0637-6_bib41","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3390\/v9080232","article-title":"Human papillomavirus and the DNA damage response: exploiting host repair pathways for viral replication","volume":"9","author":"Spriggs","year":"2017","journal-title":"Viruses"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-0637-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-0637-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222004008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222004008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-0637-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:32:39Z","timestamp":1760229159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222004008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0893395222004008"],"URL":"https:\/\/doi.org\/10.1038\/s41379-020-0637-6","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment algorithm and prognostic factors for patients with stage I\u2013III carcinoma of the anal canal: a 20-year multicenter study","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-020-0637-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}